使用全反式维甲酸加低剂量伊达比星成功治疗高龄高危急性早幼粒细胞白血病患者 - Suppr | 超能文献

Successful treatment of high-risk acute promyelocytic leukemia in very elderly patients using all-trans retinoic acid plus reduced-dose idarubicin.

作者信息

Fujisawa Takao, Takeda June, Aoki Kazunari, Ishikawa Takayuki

机构信息

Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.

出版信息

Ann Hematol. 2014 Sep;93(9):1621-3. doi: 10.1007/s00277-013-1995-7. Epub 2014 Jan 8.

DOI:10.1007/s00277-013-1995-7

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Successful treatment of high-risk acute promyelocytic leukemia in very elderly patients using all-trans retinoic acid plus reduced-dose idarubicin.使用全反式维甲酸加低剂量伊达比星成功治疗高龄高危急性早幼粒细胞白血病患者

Ann Hematol. 2014 Sep;93(9):1621-3. doi: 10.1007/s00277-013-1995-7. Epub 2014 Jan 8.

2

Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols.老年（≥60岁）新诊断急性早幼粒细胞白血病患者的治疗。意大利多中心研究组GIMEMA采用全反式维甲酸和伊达比星（AIDA）方案的结果。

Leukemia. 2003 Jun;17(6):1085-90. doi: 10.1038/sj.leu.2402932.

3

Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin.在使用全反式维甲酸和伊达比星进行诱导治疗期间发生维甲酸综合征的急性早幼粒细胞白血病患者的临床和生物学特征。

Haematologica. 2008 Dec;93(12):1918-20. doi: 10.3324/haematol.13510. Epub 2008 Oct 22.

4

Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia.新诊断的急性早幼粒细胞白血病患者经低剂量全反式维甲酸联合小剂量化疗诱导缓解后，加用静脉注射三氧化二砷巩固治疗的长期疗效。

Hematol Oncol. 2014 Mar;32(1):40-6. doi: 10.1002/hon.2076. Epub 2013 Aug 20.

5

Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention.接受全反式维甲酸和蒽环类药物为基础的化疗作为一线治疗失败的急性早幼粒细胞白血病患者的结局（PETHEMA方案LPA96和LPA99）：早期干预的益处

Leukemia. 2007 Mar;21(3):446-52. doi: 10.1038/sj.leu.2404501. Epub 2007 Jan 4.

6

Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report.

Blood Coagul Fibrinolysis. 2008 Oct;19(7):721-3. doi: 10.1097/MBC.0b013e3282fe7405.

7

Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemia.急性早幼粒细胞白血病中全反式维甲酸诱导缓解治疗与标准化疗的发病率及成本比较

Leukemia. 1994 Jun;8(6):934-9.

8

Could ATRA/Idarubicin treatment of acute promyelocytic leukemia induce the appearance of new clonal cytogenetic abnormalities in patients in complete remission?

Leuk Res. 2007 Sep;31(9):1315-7. doi: 10.1016/j.leukres.2006.10.003. Epub 2006 Nov 7.

9

Massive postpartum hemorrhage after chemotherapy in a patient with acute promyelocytic leukemia.

J Obstet Gynaecol Res. 2011 Nov;37(11):1759-63. doi: 10.1111/j.1447-0756.2011.01598.x. Epub 2011 Jul 25.

10

Time to abandon traditional chemotherapy for acute promyelocytic leukaemia?

Lancet Oncol. 2015 Oct;16(13):1274-5. doi: 10.1016/S1470-2045(15)00210-7. Epub 2015 Sep 14.

引用本文的文献

1

Identification of compounds that modulate retinol signaling using a cell-based qHTS assay.使用基于细胞的定量高通量筛选分析方法鉴定调节视黄醇信号传导的化合物。

Toxicol In Vitro. 2016 Apr;32:287-96. doi: 10.1016/j.tiv.2016.01.011. Epub 2016 Jan 25.